Fact-checked by Grok 2 weeks ago

Frizzled

Frizzled (FZD) proteins constitute a family of seven-transmembrane-spanning receptors that primarily function as the core receptors for Wnt ligands in metazoans, playing essential roles in diverse cellular processes such as , , and establishment. In humans and other vertebrates, there are ten Frizzled genes (FZD1–10), encoding proteins typically comprising 500–700 , featuring an extracellular cysteine-rich domain (CRD) for binding, seven hydrophobic transmembrane helices characteristic of G protein-coupled receptors (GPCRs), and an intracellular C-terminal tail for . These receptors are phylogenetically grouped into five subgroups (FZD1/2/7, FZD3/6, FZD4, FZD5/8, and FZD9/10), with structural variations including N- and sites and motifs for post-translational modifications like palmitoylation and phosphorylation that regulate their activity and trafficking. Frizzled receptors mediate Wnt signaling through both canonical and non-canonical pathways, with the canonical Wnt/β-catenin pathway being the most studied. In this pathway, Wnt ligands bind to the CRD of Frizzled with high affinity (Kd 1–10 nM), inducing the formation of a ternary complex with co-receptors /6, which recruits the adaptor protein (DVL) and inhibits the β-catenin destruction complex, leading to β-catenin stabilization, nuclear translocation, and activation of target gene transcription. Non-canonical pathways, including (PCP) and Wnt/Ca²⁺ signaling, involve Frizzled interactions with additional effectors like or RYK co-receptors, regulating cytoskeletal dynamics and calcium release without β-catenin involvement. Frizzled signaling is tightly regulated by ubiquitination (e.g., via RING finger proteins ZNRF3/RNF43), , and feedback mechanisms to prevent aberrant activation. Beyond development, where Frizzled receptors are indispensable for embryonic patterning, , and formation—as evidenced by phenotypes in model like Drosophila (four Fz genes) and C. elegans (four Cfz genes)—dysregulated Frizzled activity contributes to pathologies such as developmental disorders and cancers. For instance, mutations in FZD4 cause familial exudative vitreoretinopathy, while overexpression or aberrant Wnt-Frizzled signaling drives tumorigenesis in colorectal, , and other cancers by promoting uncontrolled and . Ongoing highlights Frizzled as therapeutic targets, with inhibitors like monoclonal antibodies targeting specific subtypes showing promise in reducing tumor growth in preclinical models.

Discovery and Overview

Historical Discovery

The frizzled (fz) gene was initially identified in Drosophila melanogaster in 1989 as a genetic locus required for planar cell polarity in epidermal structures, such as the orientation of bristles and hairs on the wing and abdomen. This discovery revealed that the gene encodes a protein with seven potential transmembrane domains, suggesting a role in cell surface signaling. In the early 1990s, researchers cloned the first mammalian homologs of frizzled, marking the expansion of the family beyond invertebrates. Specifically, FZD1 and FZD2 were isolated in 1992 from a rat osteosarcoma cell cDNA library, demonstrating sequence similarity to the Drosophila protein and widespread expression in tissues like kidney, liver, heart, uterus, and ovary. Between 1996 and 1998, frizzled proteins were recognized as receptors for Wnt signaling ligands, with studies establishing their functional links to downstream components like Dishevelled and the stabilization of β-catenin. For instance, in 1996, a Drosophila frizzled homolog was shown to act as a receptor for Wingless, the fly ortholog of vertebrate Wnt proteins, thereby initiating polarity and patterning signals. These findings positioned frizzled as central mediators in Wnt-dependent processes, such as embryonic development and tissue homeostasis. A influential 2004 review synthesized these advances, classifying frizzled receptors as G-protein-coupled receptors capable of transducing diverse signals beyond Wnt pathways.

Definition and General Characteristics

Frizzled receptors constitute a of G protein-coupled receptors (GPCRs) classified within the F , comprising 10 members in humans designated FZD1 through FZD10. These receptors are characterized by a seven-transmembrane typical of GPCRs, yet they diverge from classical A and B GPCRs by lacking conserved motifs such as the sequence at the end of transmembrane 3, which is essential for conventional G protein coupling in many GPCRs. Instead, Frizzled receptors primarily transduce signals through interactions with intracellular scaffold proteins rather than direct activation, although emerging evidence indicates selective G protein involvement in certain contexts. The primary function of Frizzled receptors is to serve as cell surface receptors for secreted Wnt glycoproteins, a family of lipid-modified signaling molecules that play pivotal roles in embryonic development, tissue homeostasis, and regulation. Upon Wnt binding, Frizzled receptors recruit and activate the intracellular adaptor protein (DVL), which initiates downstream signaling cascades. This activation is facilitated by the receptors' general topological architecture, which includes an N-terminal extracellular cysteine-rich domain (CRD) responsible for ligand recognition, a bundle of seven-pass transmembrane helices that span the plasma membrane to propagate the signal, and a C-terminal intracellular tail that interacts with cytosolic effectors like DVL. A hallmark of the Frizzled family is the high conservation of structural features within the CRD, particularly the presence of 10 invariant residues across all members, which form five intramolecular bonds to stabilize the domain's fold and enable high-affinity binding to Wnt ligands. This CRD, approximately 120 in length, adopts a compact β-sheet-rich structure that presents a hydrophobic groove for accommodating the palmitoylated of Wnt proteins, underscoring the evolutionary adaptation of Frizzled receptors for specific interactions. The intracellular C-terminal tail, varying in length among isoforms, often concludes with motifs that facilitate assembly of multiprotein signaling complexes, further distinguishing Frizzled from traditional GPCRs in their reliance on non-canonical transduction mechanisms.

Molecular Structure

Extracellular Cysteine-Rich Domain

The extracellular cysteine-rich domain (CRD) of Frizzled receptors serves as the primary N-terminal region for Wnt recognition, spanning approximately 120 and positioned extracellularly to initiate signaling upon binding. This domain is essential for the receptor's function, as it directly interacts with Wnt proteins to activate downstream pathways. Structurally, the CRD features 10 highly conserved cysteine residues that form five intramolecular bridges, stabilizing a compact β-sheet-rich fold characteristic of the Frizzled family. This architecture creates a positively charged electrostatic surface on one face of the domain, which facilitates interaction with the lipid-modified N-terminal palmitate group of Wnt . The bonds ensure structural integrity, with studies confirming their role in maintaining Wnt-binding competence. Insights from crystallographic analyses, such as the structure of the Frizzled-8 CRD (PDB: 1IJ7), reveal a compact domain with exposed hydrophobic grooves that accommodate the palmitoylated thumb loop of Wnt proteins. Subsequent complex structures, including the 2012 Xenopus Wnt8– Frizzled-8 CRD (PDB: 4F0A), demonstrate how these grooves enable specific insertion of the Wnt moiety, promoting high-affinity with constants in the nanomolar range. These structural details highlight the CRD's role in specificity, independent of the receptor's transmembrane regions. The CRD also confers pathway selectivity among Frizzled subtypes; for instance, the Frizzled-8 CRD exhibits a preference for ligands like Wnt3a, facilitating β-catenin-dependent signaling over non-canonical routes. This selectivity arises from variations in the CRD's binding pocket, allowing differential engagement of Wnt isoforms despite overall sequence conservation across the family.

Transmembrane and Intracellular Regions

The of Frizzled receptors consists of seven alpha-helices that span the plasma membrane, forming a 7TMR (seven-transmembrane receptor) characteristic of class F G -coupled receptors (GPCRs). This heptahelical bundle is atypical among GPCRs due to the absence of the conserved DRY motif at the cytoplasmic end of transmembrane helix 3, which is essential for classical G activation in class A GPCRs. Instead, Frizzleds primarily initiate signaling through recruitment of the cytosolic scaffold Dishevelled, bypassing direct G coupling in the Wnt pathway. The intracellular regions include three cytoplasmic loops and a C-terminal , with the latter varying in length from approximately 30 to 150 residues across Frizzled family members. This is largely intrinsically disordered, contributing to its flexibility, and contains a highly conserved KTxxxW motif near its end that binds the PDZ domain of , facilitating downstream . Mutations in this motif disrupt Dishevelled recruitment and impair Wnt signaling. Recent cryo-EM structures from the 2020s, such as those of human Frizzled-5, Frizzled-7, and Frizzled-8 in complex with Wnt ligands or effectors, have resolved the transmembrane helices at resolutions around 3.5–4 Å, revealing a compact bundle with specific lipid interactions stabilizing the core, including cholesterol and phospholipid binding sites. More recent examples include the 2024 cryo-EM structure of FZD4 with the DEP domain of Dishevelled 2 at 3.2 Å resolution, elucidating effector binding interfaces, and a high-resolution (1.9 Å) structure of inactive FZD7, providing details on allosteric regulation. However, the full intracellular domains, particularly the flexible C-terminal tail, remain unresolved in these models due to their dynamic nature. Upon Wnt binding to the extracellular cysteine-rich domain, the transmembrane helices undergo conformational rearrangements, such as outward tilting of helix 6, to expose intracellular interfaces for effector recruitment and signal initiation.

Classification and Evolution

Frizzled Family Members in Humans

In humans, the Frizzled (FZD) consists of ten isoforms, FZD1 through FZD10, encoded by distinct genes and classified as class F G-protein-coupled receptors that primarily mediate Wnt signaling. These receptors share overall sequence identities of 20-40% across the , with greater (50-80%) within phylogenetic subgroups: FZD1/FZD2/FZD7 (approximately 75% identity), FZD3/FZD6 (approximately 53% identity), FZD4/FZD9/FZD10 (approximately 65% identity), and FZD5/FZD8 (approximately 70% identity); the cysteine-rich (CRD) and transmembrane regions exhibit the highest among all isoforms. binding shows isoform specificity, with Wnt proteins interacting promiscuously but preferentially; for example, FZD1, FZD2, and FZD7 commonly bind non- Wnt5a, while FZD5 and FZD8 preferentially engage Wnt3a. The chromosomal locations of the FZD genes are dispersed across multiple chromosomes, reflecting their evolutionary divergence. Tissue expression patterns vary, with many isoforms prominently active in neural, cardiovascular, and reproductive tissues during development and adulthood, though some show restricted or low basal expression in normal tissues. Below is a summary of key features for each FZD isoform:
IsoformChromosomal LocationRepresentative Normal Tissue ExpressionIsoform-Specific Ligands (Examples)
FZD17q21.13 (cerebral cortex), heart (fetal), placentaWnt1, Wnt3a, Wnt5a
FZD217q21.31Widely expressed in adult and fetal tissues, including heart, , and Wnt2, Wnt3a, Wnt5a
FZD38p21Neural tissues (, )Wnt2, Wnt3a, Wnt5a
FZD411q14.2, vascular Wnt2, Wnt5a, Norrin (non-Wnt ligand)
FZD52q33.3, heart, Wnt2, Wnt3a, Wnt5a
FZD68q22.3, , Wnt3a, Wnt5a
FZD72q33.1, Wnt3a, Wnt5a, Wnt7a
FZD810p11.21, pancreas, Wnt1, Wnt3a
FZD97q11.23, testis, Wnt2
FZD1012q24.33, , heart, , Wnt3a, Wnt7b
Unique features include elevated FZD7 expression in placental trophoblasts and various tumors (e.g., colorectal, ), contributing to its role in ; FZD4's association with vasculature; and FZD10's relatively low expression in most tissues but presence in specific adult organs like the . All data are derived from genomic databases and expression studies, with variations noted across developmental stages.

Distribution and Evolutionary Conservation Across Species

Frizzled receptors are present across a wide range of metazoan phyla, from Porifera (sponges) to Chordata, underscoring their ancient role in animal development. The founding member of the family, Drosophila Frizzled (Fz), was identified through genetic screens for disruptions in epidermal cell polarity, establishing the receptor's involvement in Wnt signaling. These receptors are notably absent in non-metazoan eukaryotes, such as plants and fungi, highlighting their emergence with the evolution of multicellular animals. The evolutionary conservation of Frizzled receptors is evident in the cysteine-rich domain (CRD), which features ten invariant residues that have remained unchanged since the common of bilaterians approximately 550 million years ago. This is crucial for binding and has maintained its structure across diverse species, reflecting strong selective pressure for Wnt pathway functionality. duplications in the expanded the ancestral repertoire of four Frizzled subfamilies—Fz1/2/7, Fz4, Fz5/8, and Fz9/10—into ten paralogs in humans, enabling specialized signaling roles. Orthologs of Frizzled receptors are well-documented in model organisms, with retaining four: Fz, Fz2, Fz3, and Fz4, which correspond to the ancestral subfamilies and mediate both and non-canonical Wnt signaling. In mice, ten orthologs (Fzd1 through Fzd10) mirror the family, with expansions arising from duplications after the divergence from . These orthologs exhibit high sequence similarity in key domains, supporting conserved functions in development and across . Phylogenetic analyses reveal that the four core Frizzled subfamilies originated in the eumetazoan ancestor, with subsequent duplications leading to specialization. A fifth subfamily, Fz3/6, emerged later in chordates, coinciding with the vertebrate radiation around 500 million years ago. This divergence aligns with functional partitioning, where certain receptors (e.g., Fz1/2/7 and Fz5/8) preferentially activate canonical Wnt/β-catenin signaling, while others (e.g., Fz3/4 and Fz6) favor non-canonical pathways, as depicted in evolutionary trees clustering subfamilies by sequence and signaling bias.

Signaling Mechanisms

Canonical Wnt/β-Catenin Pathway

The canonical Wnt/β-catenin pathway represents the primary signaling cascade transduced by Frizzled (FZD) receptors in response to Wnt ligands, leading to the through β-catenin stabilization. In the absence of Wnt signaling, β-catenin is constitutively phosphorylated by the destruction complex, comprising kinase 3 (GSK3), (APC), and (CK1), marking it for ubiquitination and proteasomal degradation. Upon Wnt ligand binding, the pathway is activated when a palmitoylated Wnt protein, such as Wnt3a, engages the extracellular cysteine-rich domain of an FZD receptor and the co-receptor low-density lipoprotein receptor-related protein 5 or 6 (/6), forming a ternary complex on the cell membrane. This ligand-receptor interaction recruits the scaffold protein (DVL) to the plasma membrane, where DVL oligomerizes and binds Axin, a key component of the destruction complex, thereby inhibiting its activity and preventing β-catenin phosphorylation. The recruitment disrupts the destruction complex assembly, leading to the accumulation of unphosphorylated β-catenin in the . Stabilized β-catenin then translocates to the , where it displaces transcriptional repressors and interacts with TCF/LEF transcription factors to activate target genes, including c-Myc and , which promote and . Recent structural studies, including cryo-EM structures of the FZD4- 2 (DVL2) complex, have revealed the molecular basis of receptor and in Wnt signaling. Additionally, as of 2025, research shows that formation of the FZD-Wnt-LRP5/6 complex alone is insufficient to initiate β-catenin signaling, indicating additional regulatory steps. Specific FZD isoforms, notably FZD1, FZD5, FZD7, FZD8, and FZD10, predominantly mediate canonical Wnt signaling, with varying affinities for different palmitoylated Wnt ligands; for instance, FZD5 and FZD8 exhibit broad compatibility with Wnt3a and Wnt8a, while FZD10 shows selectivity for Wnt3 and Wnt9b.

Non-Canonical Pathways

In addition to the canonical Wnt/β-catenin pathway, Frizzled receptors mediate non-canonical signaling cascades that regulate cellular processes such as polarity, migration, and cytoskeletal dynamics without involving β-catenin stabilization. These pathways include the planar cell polarity (PCP) pathway and the Wnt/Ca²⁺ pathway, which are activated by specific Wnt ligands binding to Frizzled receptors, often in conjunction with co-receptors, leading to downstream effects on the actin cytoskeleton and intracellular calcium levels. The PCP pathway, a core non-canonical route, involves Frizzled receptors recruiting Dishevelled (Dvl) upon Wnt ligand binding, which phosphorylates Dvl and initiates a signaling cascade promoting cytoskeletal reorganization. Dvl activation recruits Daam1, which in turn activates RhoA (leading to ROCK-mediated actomyosin contractility) and Rac1 (activating JNK for c-Jun phosphorylation and gene expression), thereby coordinating planar polarity and directed cell movements essential for tissue organization. This pathway is exemplified in Drosophila wing and eye development, where Frizzled coordinates asymmetric protein localization to establish tissue-wide polarity. The Wnt/Ca²⁺ pathway operates through G protein-coupled Frizzled activation, where Wnt ligands such as Wnt5a bind to specific Frizzled receptors, stimulating (PLC) to generate (IP3) and diacylglycerol (DAG). IP3 triggers intracellular Ca²⁺ release, which activates to dephosphorylate NFAT for nuclear translocation and gene transcription, while also engaging CaMKII (activating TAK1 and NLK) and PKC (via DAG and Ca²⁺, promoting Cdc42-mediated polymerization). This calcium-dependent signaling influences , , and fate decisions during embryogenesis. Specific Frizzled isoforms exhibit preferential involvement in these pathways; for instance, FZD3 and FZD6 are key mediators of signaling, where their combined activity is required for closure, as double knockout in mice results in craniorachischisis due to defective convergent extension movements. In contrast, FZD2 and FZD7 primarily drive Wnt5a-induced Ca²⁺ signaling, with FZD2 activation leading to elevated intracellular calcium and PKC stimulation in neural and embryonic contexts. Non-canonical pathways also exhibit cross-talk with canonical signaling, often inhibitory, through co-receptors like ROR1/2 and RYK, which form complexes with Frizzled to sequester Wnt ligands or activate competing downstream effectors. For example, Wnt5a binding to ROR2-FZD2 heterodimers promotes or Ca²⁺ signaling while antagonizing β-catenin accumulation, thereby fine-tuning pathway specificity during development and preventing aberrant canonical activation.

Biological Roles

In Embryonic Development and

In , the Frizzled (Fz) receptor plays a pivotal role in establishing planar () during embryonic and pupal development, directing the asymmetric orientation of epidermal hairs and sensory bristles through the core PCP signaling pathway. Mutations in fz lead to characteristic swirling patterns of wing hairs and randomized bristle orientations, as Fz asymmetrically localizes to the distal edges of epithelial cells, coordinating downstream effectors like and Van Gogh to polarize the for hair initiation at the distal vertex. This process ensures coordinated tissue-wide polarity, essential for proper wing and cuticle formation. In embryonic development, specific Frizzled homologs contribute to key morphogenetic events. FZD7 is critical for convergent extension movements during , where it mediates Wnt11 signaling to regulate cell intercalation and tissue elongation via the non-canonical pathway, with knockdown resulting in shortened anterior-posterior axes and defective closure. Similarly, FZD7 contributes to paraxial differentiation during somitogenesis in vertebrates such as . FZD3, meanwhile, is essential for cell migration and ; in , it transduces Wnt signals to induce neural crest specification and directed migration, while in mice, Fzd3 mutants exhibit disrupted cranial neural crest and defects. For , Fzd3 controls anterior-posterior polarity in commissural and hippocampal axons by interacting with Celsr3 to form guidance scaffolds in the developing CNS. Frizzled receptors establish by localizing to distal membrane edges in polarized epithelia, where they integrate cytoskeletal dynamics to drive oriented protrusions. In wing cells, Fz is transported along polarized to distal sites, recruiting actin regulators like Flamingo to stabilize -based hairs and ensure directional outgrowth. This localization creates an asymmetry that propagates across tissues via intercellular interactions, coordinating orientation and polymerization for collective . Knockout studies highlight Frizzled's necessity in vascular development during embryogenesis. In mice, Fzd4-null mutants display severe retinal and inner ear vascular defects, including incomplete hyaloid vessel regression and labyrinthine hypovascularization, due to impaired endothelial migration and tube formation mediated by Norrin-Fzd4 signaling. Human mutations in FZD4, first identified in 2002 but further characterized in 2004 linkage studies, cause familial exudative vitreoretinopathy (FEVR), an inherited disorder featuring abnormal retinal angiogenesis, peripheral avascularity, and neovascularization, underscoring FZD4's conserved role in embryonic vascular patterning.

In Adult Physiology and Pathophysiology

In organisms, Frizzled receptors contribute to tissue homeostasis by regulating vascular and skeletal maintenance as well as regeneration. FZD5, a receptor for and non-canonical Wnt ligands, plays a key role in endothelial cell function, promoting through activation of nuclear factor of activated T-cells cytoplasmic 3 (NFATc3), which supports vascular stability in mature tissues such as the and peripheral circulation. Additionally, FZD5 expression in s is upregulated by Wnt signaling, facilitating osteoblast differentiation and bone formation to maintain skeletal integrity during adulthood. FZD6, primarily involved in planar cell polarity () signaling, ensures proper orientation of follicles in , which is essential for coordinated and epidermal ; disruptions in FZD6 lead to misaligned follicles and impaired regenerative cycles. In , aberrant Frizzled activation drives oncogenic processes in several cancers. Overexpression of FZD7, a receptor for Wnt ligands like Wnt3a, is frequently observed in , where it enhances β-catenin stabilization and promotes tumor cell proliferation independent of mutations. Similarly, in , elevated FZD7 levels correlate with increased Wnt signaling, sustaining cancer maintenance and proliferative capacity. FZD10 contributes to progression, with its expression peaking in premalignant lesions before declining in advanced stages. Frizzled mutations and dysregulation are also implicated in non-oncologic diseases affecting and neurodevelopment. Mutations in FZD4 disrupt Norrin and canonical Wnt signaling in retinal vasculature, leading to familial exudative vitreoretinopathy with Norrie disease-like features, including and vascular leakage. In the , FZD3 alterations impair synaptic Wnt signaling, contributing to disruptions associated with through dysregulated postsynaptic transcription and morphology. Recent investigations since 2020 have highlighted Frizzled involvement in fibrotic and neurodegenerative conditions. Non-canonical Wnt11 signaling in fibroblasts drives and deposition in models, exacerbating stiffness and decline in function. FZD8 has been implicated in modulating production in . In models, FZD3 modulates GSK3β activity via NEAT1, influencing and stability, with variants in FZD3 linked to increased risk in human cohorts.

Therapeutic Potential

As Targets for Drug Development

Frizzled receptors have emerged as promising targets for pharmacological intervention due to their central role in Wnt signaling dysregulation in diseases such as cancer. Monoclonal antibodies represent a key class of direct Frizzled-targeting agents. , binds to Frizzled receptors 1, 2, 5, 7, and 8, thereby inhibiting canonical Wnt/β-catenin signaling by preventing binding and subsequent receptor activation. This blockade reduces tumor growth and sensitizes cancer stem cells to in preclinical models. In clinical development during the , vantictumab advanced to phase I and Ib trials for advanced solid tumors, including a dose-escalation combined with in HER2-negative , where it demonstrated an overall response rate of 31.3% and median of 3.8 months. However, fractures and other toxicities led to discontinuation of trials in 2018. In August 2025, Mereo BioPharma licensed vantictumab to āshibio for development in autosomal dominant osteopetrosis type 2 (ADO2), a rare , leveraging prior safety data to advance into clinical trials. Small-molecule inhibitors offer an alternative strategy by indirectly modulating Frizzled activity through upstream interference in the Wnt pathway. LGK974 (also known as WNT974), a potent and selective inhibitor of (PORCN), targets the O-acyltransferase enzyme responsible for Wnt ligand palmitoylation, thereby blocking Wnt secretion and preventing ligand-induced activation of Frizzled receptors. With an of 0.4 nM in Wnt signaling assays, LGK974 reduces LRP6 and expression of Wnt target genes like AXIN2, leading to tumor regression in preclinical models such as MMTV-Wnt1-driven mammary tumors (tumor/control ratio of -63% at 3 mg/kg). LGK974 remains in phase I/II clinical trials for advanced solid tumors, including , as of 2025. For retinopathy, Frizzled-4 (FZD4) modulation focuses on agonists rather than antagonists; SZN-413, a bispecific FZD4-LRP5 , activates Wnt/β-catenin signaling to promote vascular regeneration and reduce in oxygen-induced retinopathy mouse models (P < 0.001) and VEGF-induced leakage in rabbits (~80% reduction, P < 0.01). In September 2024, licensed SZN-413 from Surrozen for clinical development in retinal diseases, including . Developing Frizzled-targeted drugs faces significant challenges, including extensive pathway cross-talk and the high among the 10 Frizzled isoforms, which necessitates isoform-specific agents to minimize off-target and adverse effects on normal Wnt-dependent tissues like . Many reported Frizzled modulators exhibit low selectivity, as seen with broad-spectrum antibodies like OMP-18R5 that affect multiple isoforms and raise concerns such as fractures. Advances in 2023 include bispecific antibody-based Wnt mimetics that simultaneously bind specific Frizzled subtypes (e.g., FZD1, 2, 4, 5, 7, 8, 9, 10) and /6 co-receptors to precisely modulate FZD-LRP complexes, enabling selective activation of Wnt/β-catenin signaling in target tissues like salivary glands and organoids without relying on endogenous R-spondins. These Fv-IgG format constructs cover all canonical Wnt-activating Frizzeds, offering stable tools for therapeutic development. Preclinical validation of Frizzled targeting often involves knockdown models demonstrating reduced tumor progression. For instance, shRNA-mediated knockdown of Frizzled-5 (FZD5) in cells (SKOV3) implanted as subcutaneous xenografts in nude mice resulted in slower tumor growth over 4 weeks compared to controls, with further suppression when combined with (5 mg/kg). Similarly, Frizzled-7 (FZD7) knockdown or antibody blockade inhibits xenograft tumor volume in models of gastric, breast, and pancreatic cancers, underscoring the pathway's role in tumor maintenance. These findings support Frizzled as a viable target, though isoform specificity remains crucial for clinical translation.

Clinical Implications in Diseases

Frizzled receptors, particularly FZD7, have been implicated in various cancers driven by dysregulated Wnt signaling, serving as potential biomarkers for tumor progression and . In , where the Wnt/β-catenin pathway is aberrantly activated in approximately 90% of cases due to in or other components, FZD7 overexpression is frequently observed in tumor tissues compared to adjacent normal tissues and correlates with poor patient survival. Similarly, clinical trials evaluating Frizzled inhibitors, such as the Wnt trap ipafricept (a decoy receptor targeting Frizzled ligands), in combination with standard were conducted in ; for instance, a phase Ib study (NCT02050178) assessed its safety and efficacy in untreated metastatic cases, showing preliminary tolerability but limited benefits. Development of ipafricept was discontinued in 2018 due to bone toxicity concerns. Mutations in FZD4 are a significant cause of familial exudative vitreoretinopathy (FEVR), an inherited retinal vascular disorder characterized by incomplete vascularization of the peripheral retina. These mutations account for roughly 30% of explainable FEVR cases, leading to disrupted Norrin/Wnt signaling essential for retinal angiogenesis and resulting in symptoms like retinal detachment and vision loss. Beyond oncology and ocular disorders, Frizzled receptors contribute to other pathologies; for example, FZD5 activation via Wnt5a signaling enhances endothelial cell migration and proliferation in diabetic retinopathy, exacerbating retinal neovascularization in hyperglycemia. Non-canonical Wnt signaling, including via receptors like FZD8, has been implicated in lung fibrosis models, promoting extracellular matrix deposition in fibroblasts. Frizzled expression profiling holds diagnostic potential for prognosis in , with high levels of certain receptors like FZD8 or FZD6 associated with adverse outcomes such as and reduced , enabling risk stratification through tumor analysis.

References

  1. [1]
    The Frizzled family: receptors for multiple signal transduction pathways
    Frizzled genes encode integral membrane proteins that function in multiple signal transduction pathways in animals. They are receptors for secreted Wnt proteins ...
  2. [2]
    The emerging understanding of Frizzled receptors - FEBS Press
    May 14, 2024 · The Frizzled (Fzd) family proteins comprises receptors for Wnt ligands, which indispensably mediate Wnt signaling jointly with a variety of ...Abstract · Abbreviations · FZD protein structures and... · The regulation of FZD
  3. [3]
    Frizzled and LRP5/6 Receptors for Wnt/β-Catenin Signaling - PMC
    In this study, we review the current knowledge of these two families of receptors, including their structures and interactions with Wnt proteins, and signaling ...
  4. [4]
    A Drosophila tissue polarity locus encodes a protein containing ...
    Mar 16, 1989 · A Drosophila tissue polarity locus encodes a protein containing seven potential transmembrane domains. Charles R. Vinson,; Sharon Conover & ...
  5. [5]
    A Drosophila Tissue Polarity Locus Encodes a Protein ... - PubMed
    Nature. 1989 Mar 16;338(6212):263-4. doi: 10.1038/338263a0. Authors. C R Vinson , S Conover, P N Adler. Affiliation. 1 Biology Department, University of ...
  6. [6]
    Two homologs of the Drosophila polarity gene frizzled (fz ... - PubMed
    Two homologs of the Drosophila polarity gene frizzled (fz) are widely expressed in mammalian tissues. J Biol Chem. 1992 Dec 15;267(35):25202-7.
  7. [7]
    new members of the superfamily of G-protein-coupled receptors
    May 1, 2004 · PMID: 14977528; DOI: 10.2741/1308. Abstract. The superfamily of membrane receptors that signal via heterotrimeric G-proteins includes more than ...
  8. [8]
    A new member of the frizzled family from Drosophila functions as a ...
    Jul 18, 1996 · Vinson, C. R., Conover, S. & Adler, P. N. Nature 338, 263–264 (1989). Article ADS CAS Google Scholar. Adler, P. N., Vinson, C., Park, W. J. ...
  9. [9]
  10. [10]
  11. [11]
  12. [12]
    WNT/Frizzled signalling: receptor–ligand selectivity with focus on ...
    For example, they lack the DRY motif at the C-terminal end of the third transmembrane domain known to be important for G protein coupling and specificity ( ...
  13. [13]
    Structural basis of Frizzled 4 in recognition of Dishevelled 2 unveils ...
    Sep 2, 2024 · Here, we present the cryo-EM structure of FZD4 engaged with the DEP domain of Dishevelled 2 (DVL2), a key WNT transducer.
  14. [14]
    Wnt/β-catenin signaling requires interaction of the Dishevelled DEP ...
    Mar 12, 2012 · Over a decade ago, a conserved linear motif was identified in the Fz C-terminal tail (KTxxxW) that mediates membrane relocalization of Dvl and ...
  15. [15]
    Direct Binding of the PDZ Domain of Dishevelled to a Conserved ...
    One peptide that binds to the mDvl1 PDZ domain is the conserved motif (KTXXXW) of Fz, which is located two amino acids after the seventh transmembrane domain ( ...Article · Results And Discussion · Binding Of The Fz C Terminus...
  16. [16]
    Structure of human Frizzled5 by fiducial-assisted cryo-EM supports a ...
    Here we report the structure of an unliganded human Fzd5 determined by single-particle cryo-EM at 3.7 Å resolution, with the aid of an antibody chaperone ...
  17. [17]
    Cryo-EM structure of constitutively active human Frizzled 7 ... - Nature
    Jul 8, 2021 · The helical arrangement at the upper portion of the FZD7 transmembrane core is more compact, presumably due to the absence of ligand ( ...
  18. [18]
    Structure of the Wnt–Frizzled–LRP6 initiation complex reveals the ...
    The structure of the signaling-competent Wnt–Frizzled–LRP6 complex reveals the basis for initiating canonical Wnt/β-catenin signaling.<|control11|><|separator|>
  19. [19]
    Frizzled Receptors as Potential Therapeutic Targets in Human ... - NIH
    May 22, 2018 · The frizzled receptors (FZDs) are comprised of ten members (FZD1–FZD10). The common characteristics of these members include an N-terminal ...Missing: similarity | Show results with:similarity
  20. [20]
    The Frizzled family: receptors for multiple signal transduction pathways
    Jun 14, 2004 · A motif (KTXXXW) located two amino acids after the seventh hydrophobic domain is highly conserved in Frizzleds and is essential for activation ...Missing: DRY | Show results with:DRY
  21. [21]
    Frizzled homolog proteins, microRNAs and Wnt Signaling in Cancer
    FZD10. Human FZD10 has been mapped to chromosome 12q24. 33 (103) and found to be expressed in adult normal placenta, brain, heart, lung, skeletal muscle, ...Missing: identity | Show results with:identity
  22. [22]
    Frizzled Receptors as Potential Therapeutic Targets in Human ...
    FZD1, FZD2, and FZD7 share about 75% identity with each other, FZD4, FZD9, and FZD10 share 65% identity, FZD5 and FZD8 share 70% identity, FZD3 and FZD6 share ...
  23. [23]
    FZD1 Gene - GeneCards | FZD1 Protein | FZD1 Antibody
    This gene is overexpressed in Ovary (18.7), Cerebral cortex (16.5), Seminal vesicle (10.5), Placenta (8.3), and Fetal heart (8.0). Integrated Proteomics: ...<|control11|><|separator|>
  24. [24]
    Tissue expression of FZD1 - Summary - The Human Protein Atlas
    The RNA data was used to cluster genes according to their expression across tissues. Clusters contain genes that have similar expression patterns, and each ...
  25. [25]
    FlyBase Gene Report: Dmel\fz
    frizzled (fz) encodes the founding member of the Fz family of receptors for Wnt ligands. It is part of Wnt signaling and planar cell polarity pathways.
  26. [26]
    The evolution and expression of panarthropod frizzled genes
    Aug 20, 2015 · The four subfamilies of Fz receptors also evolved early in metazoan evolution. To date, Fz receptors have been characterized mainly in mammals, ...
  27. [27]
    A genome-wide survey of the evolutionarily conserved Wnt ...
    Dec 1, 2006 · Thus, as for the Wnt subfamilies, the Frizzled subfamilies appear to be well conserved through the animal kingdom. Only one subfamily, Fz3/6 ...Results · Wnt Family · Frizzled FamilyMissing: across | Show results with:across
  28. [28]
    Frizzled receptors (FZD) play multiple cellular roles in development ...
    FZDs are expressed on the surfaces of WNT-responsive cells and act as receptors for WNT ligands (Bhanot et al., 1999). FZDs were first identified in Drosophila ...Missing: recognized | Show results with:recognized
  29. [29]
    Structure, phylogeny, and expression of the frizzled-related gene ...
    Dec 4, 2015 · Here we ascertain the frizzled-related gene complement in six lophotrochozoan species, and determine their spatial and temporal expression pattern.
  30. [30]
    Wnt/β-catenin signalling: function, biological mechanisms ... - Nature
    Jan 3, 2022 · The cell membrane segment mainly contains the Wnt receptors Frizzled (specific sevenfold transmembrane receptor Frizzled protein) and LRP5/6.
  31. [31]
    Wnt/β-catenin signaling: components, mechanisms, and diseases
    Here we review recent progresses in this so-called canonical Wnt signaling pathway. We discuss Wnt ligands, agonists and antagonists and their interactions with ...
  32. [32]
    Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting ...
    Here we generated cell lines with multiplex mutant alleles of FZD1, FZD2, and FZD7 and demonstrate that these cells are unresponsive to canonical Wnt ligands.
  33. [33]
    Canonical and noncanonical Wnt signaling: Multilayered mediators ...
    Huang H.C., Klein P.S. The Frizzled family: receptors for multiple signal transduction pathways. Genome Biol. 2004;5(7):234. doi: 10.1186/gb-2004-5-7-234.
  34. [34]
    Wnt-Frizzled/Planar Cell Polarity Signaling: Cellular Orientation by ...
    This review focuses on new insights into the core Fz/Vangl/PCP pathway and recent advances in Drosophila and vertebrate PCP studies.
  35. [35]
    The frizzled/stan Pathway and Planar Cell Polarity in the Drosophila ...
    Drosophila has been the key model system for studies on Planar Cell Polarity (PCP). The rich morphology of the insect exoskeleton contains many structures ...
  36. [36]
    Wnt/Ca2+ signaling pathway: a brief overview - Oxford Academic
    Sep 7, 2011 · This review will give a brief overview of Wnt/Ca 2+ signal transduction pathway with reference to development, cancer, cellular response as a consequence of ...<|separator|>
  37. [37]
    Wnt signaling pathways in biology and disease - Nature
    Apr 4, 2025 · The canonical Wnt/β-catenin signaling pathway is central to the regulation of target gene expression within the nucleus (Fig. 1). In the absence ...
  38. [38]
    Fzd3 and Fzd6 deficiency results in a severe midbrain ...
    Oct 19, 2009 · Fzd3 is expressed throughout the mouse anterior neural tube, whereas Fzd6 is restricted to the MHR. ... The cephalic neural tube closure defect ...
  39. [39]
    Genetic analysis of Wnt/PCP genes in neural tube defects
    Apr 4, 2018 · In addition, double but not single knockouts at Fzd3 and Fzd6 [4], as well as Dvls [5, 6] result in the NTD known as craniorachischisis in mice.
  40. [40]
    Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor ...
    May 17, 2016 · Frizzled receptors can homo- or hetero-polymerise and associate with several co-receptors to transmit Wnt signalling. Notably, Frizzled7 can ...6. Frizzled 7 · Regulation Of Fzd7 · 16. Targeting Fzd7 For The...
  41. [41]
    WNT-5A: signaling and functions in health and disease
    Oct 29, 2015 · WNT-5A has been shown to bind to FZD2 inducing intracellular calcium release and PKC activation in Xenopus [51] and zebrafish embryos [52] and ...
  42. [42]
    The Role of Ryk and Ror Receptor Tyrosine Kinases in Wnt Signal ...
    Ryk and Ror receptors, with Wnt-binding domains, control cell migration and may act as stand-alone or co-receptors in Wnt signaling.
  43. [43]
    Frizzled/RYK mediated signalling in axon guidance | Development
    Nov 15, 2006 · Biochemical and genetic studies support the existence of antagonistic crosstalk between the Wnt canonical and non-canonical pathway in different ...
  44. [44]
    Role of frizzled 7 in the regulation of convergent extension ... - PubMed
    We describe the expression and functional analyses of frizzled 7 (Xfz7) during gastrulation in Xenopus. Low levels of Xfz7 transcripts are expressed maternally ...Missing: seminal paper
  45. [45]
    Frizzled3 controls axonal development in distinct populations ... - eLife
    Dec 17, 2013 · Among Frizzled receptors, Fz3 is unique in its role in controlling axon guidance in the central nervous system (CNS), where it is required for ...Missing: FZD3 key
  46. [46]
    Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative ...
    Mutations in FZD4, encoding the putative Wnt receptor frizzled-4, segregated completely with affected individuals in the family and were detected in ...Missing: 2004 paper
  47. [47]
    Wnt signalling in osteoblasts regulates expression of the receptor ...
    Apr 1, 2006 · 1A), Frizzled receptors (FZD2, FZD3, FZD4, FZD5, FZD6, Fig. 1B) and ... bone formation in adult mice. Mol. Endocrinol. 18. ,. 1222. -1237 ...Expression Of Wnt Signalling... · Wnt Signalling Regulates... · Discussion<|control11|><|separator|>
  48. [48]
    Patterning skin by planar cell polarity: the multi-talented hair designer
    Core PCP genes control hair follicle orientation. Proteins encoded by homologues of three Drosophila core PCP genes, Fzd6, Vangl2, and Celsr1, are polarized in ...
  49. [49]
    Frizzled-7 as a Potential Therapeutic Target in Colorectal Cancer - NIH
    Our present data demonstrated that FZD7 activates the canonical Wnt pathway in colon cancer cells despite the presence of APC or CTNNB1 mutation.Missing: breast | Show results with:breast
  50. [50]
    FZD7 has a critical role in cell proliferation in triple negative breast ...
    May 2, 2011 · In vivo studies revealed that FZD7shRNA significantly suppressed tumor formation, through reduced cell proliferation, in mice bearing xenografts ...
  51. [51]
    Frizzled receptors in melanomagenesis: From molecular interactions ...
    Dec 23, 2022 · The significance of the dynamic expression of FZD10 in melanoma is unknown. ... WNT5A enhances resistance of melanoma cells to targeted ...
  52. [52]
    Overview of the mutation spectrum in familial exudative ...
    Mar 25, 2010 · Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, ...
  53. [53]
    Synaptic Wnt signaling—a contributor to major psychiatric disorders?
    For example, Fzd proteins have been linked to synapse formation in two quite disparate ways. First, Fzd2 has been shown to regulate postsynaptic transcription ...
  54. [54]
    Noncanonical Wnt Signaling Promotes Myofibroblast Differentiation ...
    Oct 30, 2020 · This study showed significantly higher levels of Wnt11 expression in cells from both patients with idiopathic pulmonary fibrosis and bleomycin- ...
  55. [55]
    NEAT1 regulates microtubule stabilization via FZD3/GSK3β/P-tau ...
    Nov 18, 2020 · NEAT1 regulates microtubule stabilization via FZD3/GSK3β/P-tau pathway and influences FZD3 transcription activity in the epigenetic way.
  56. [56]
    Non-coding variants in MYH11, FZD3, and SORCS3 are associated ...
    Our multiethnic studies identified significant associations between variants within APOE, MYH11, FZD3, SORCS3, and GOLGA8B and risk of dementia.
  57. [57]
    Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP ...
    This phase Ib dose escalation study enrolled patients with locally recurrent or metastatic HER2-negative breast cancer who were treated with weekly paclitaxel.
  58. [58]
    Targeting Wnt-driven cancer through the inhibition of Porcupine by ...
    This effort led to the discovery of LGK974, a potent and specific PORCN inhibitor. We show that LGK974 potently inhibits Wnt signaling in vitro and in vivo and ...
  59. [59]
    SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the ...
    Sep 23, 2022 · Wnt Receptor Expression Profiles from Retinal Vascular Endothelial Cells. Human and rodent genetics have identified FZD4 and low-density ...
  60. [60]
    Progress in the development of modulators targeting Frizzleds
    Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling.
  61. [61]
  62. [62]
    Frizzled class receptor 5 contributes to ovarian cancer ...
    Mar 27, 2024 · Our data demonstrate that xenograft tumors from cells with FZD5 knocked down grew more slowly than those from control cells (Fig. 2D, E).
  63. [63]
    Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and ...
    Targeted FZD7 knockdown reduces gastric cancer colony formation. Inhibition of cell growth following OMP-18R5 ...
  64. [64]
    Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab ...
    This phase Ib study evaluated the combination of ipafricept with nab-paclitaxel + gemcitabine in patients with untreated metastatic pancreatic adenocarcinoma ( ...
  65. [65]
    Identification of Novel FZD4 Mutations in Familial Exudative ...
    Apr 1, 2024 · All five novel mutations (S91F, V103E, C145S, E160K, C377F) responsible for FEVR were found to compromise Norrin/β-catenin activation of FZD4 ...
  66. [66]
    Update on Viral Gene Therapy Clinical Trials for Retinal Diseases
    A recent presentation at the annual ARVO meeting (2022) reported an improvement in retinal sensitivity after 12 months of treatment (ARVO oral presentation). A ...
  67. [67]
    Identification of Wnt-5a Receptors Important in Diabetic and Non ...
    Indeed, in diabetic LECs, siRNA silencing of FZD5 partially blocked wound healing. This finding suggests that diabetic cells, in the absence of enough Wnt ...
  68. [68]
    The Pathogenic Role of Smooth Muscle Cell-Derived Wnt5a in a ...
    We demonstrate that the Wnt5a expression of SMC of the airways leads to aggravated fibrosis of the lung with poor clinical conditions.
  69. [69]
    Expression pattern, prognostic value and potential microRNA ...
    Sep 21, 2023 · Increased levels of FZD8 expression were consistently associated with a poor prognosis. This refers to several clinicopathological features, ...
  70. [70]
    The Prognostic Value of the Developmental Gene FZD6 in Young ...
    Feb 13, 2022 · The death risk during all follow-up periods was 34% in patients with low FZD6 expression compared to 47% in their counterparts with high FZD6 ...